Gene · 3161
Papers2,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Radio-lncRNAs: Biological Function and Potential Use as Biomarkers for Personalized Oncology. | J Pers Med | 2022 | 36294743 | PubTator, text mining | PubMed |
| The Innate Immune Microenvironment in Metastatic Breast Cancer. | J Clin Med | 2022 | 36294305 | PubTator, text mining | PubMed |
| CEMIP, a Promising Biomarker That Promotes the Progression and Metastasis of Colorectal and Other Types of Cancer. | Cancers (Basel) | 2022 | 36291875 | PubTator, text mining | PubMed |
| Key Role of Hyaluronan Metabolism for the Development of Brain Metastases in Triple-Negative Breast Cancer. | Cells | 2022 | 36291142 | PubTator, text mining | PubMed |
| Role of hyaluronic acid in periodontal therapy (Review). | Biomed Rep | 2022 | 36278244 | PubTator, text mining | PubMed |
| Recent progress in nanocomposites of carbon dioxide fixation derived reproducible biomedical polymers. | Front Chem | 2022 | 36277338 | PubTator, text mining | PubMed |
| The complex interactions between the cellular and non-cellular components of the brain tumor microenvironmental landscape and their therapeutic implications. | Front Oncol | 2022 | 36276147 | PubTator, text mining | PubMed |
| Identifying a lactic acid metabolism-related gene signature contributes to predicting prognosis, immunotherapy efficacy, and tumor microenvironment of lung adenocarcinoma. | Front Immunol | 2022 | 36275729 | PubTator, text mining | PubMed |
| A review on the role of cyclin dependent kinases in cancers. | Cancer Cell Int | 2022 | 36266723 | PubTator, text mining | PubMed |
| Inhibition of NADPH Oxidase-ROS Signal using Hyaluronic Acid Nanoparticles for Overcoming Radioresistance in Cancer Therapy. | ACS Nano | 2022 | 36256454 | PubTator, text mining | PubMed |
| Identification of the hub and prognostic genes in liver hepatocellular carcinoma via bioinformatics analysis. | Front Mol Biosci | 2022 | 36250027 | PubTator, text mining | PubMed |
| Recognition of driver genes with potential prognostic implications in lung adenocarcinoma based on H3K79me2. | Comput Struct Biotechnol J | 2022 | 36249560 | PubTator, text mining | PubMed |
| Deregulated hyaluronan metabolism in the tumor microenvironment drives cancer inflammation and tumor-associated immune suppression. | Front Immunol | 2022 | 36238286 | PubTator, text mining | PubMed |
| Pathophysiological and Therapeutic Roles of Fascial Hyaluronan in Obesity-Related Myofascial Disease. | Int J Mol Sci | 2022 | 36233143 | PubTator, text mining | PubMed |
| Magnetic Micellar Nanovehicles: Prospects of Multifunctional Hybrid Systems for Precision Theranostics. | Int J Mol Sci | 2022 | 36233094 | PubTator, text mining | PubMed |
| A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | Int J Mol Sci | 2022 | 36232890 | PubTator, text mining | PubMed |
| The Effects of Aging on the Intramuscular Connective Tissue. | Int J Mol Sci | 2022 | 36232366 | PubTator, text mining | PubMed |
| Visceral Adipose Tissue Molecular Networks and Regulatory microRNA in Pediatric Obesity: An In Silico Approach. | Int J Mol Sci | 2022 | 36232337 | PubTator, text mining | PubMed |
| Identifying a 6-Gene Prognostic Signature for Lung Adenocarcinoma Based on Copy Number Variation and Gene Expression Data. | Oxid Med Cell Longev | 2022 | 36211815 | PubTator, text mining | PubMed |
| Versican enrichment predicts poor prognosis and response to adjuvant therapy and immunotherapy in gastric cancer. | Front Immunol | 2022 | 36203562 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3161/papers?page=22